{"nctId":"NCT00290589","briefTitle":"A Trial of Corticosteroids for Low Back Pain","startDateStruct":{"date":"2003-06"},"conditions":["Radicular Low Back Pain"],"count":82,"armGroups":[{"label":"Intramuscular methylprednisolone acetate","type":"EXPERIMENTAL","interventionNames":["Drug: Intramuscular methylprednisolone acetate"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Intramuscular methylprednisolone acetate","otherNames":["steroid"]},{"name":"Placebo","otherNames":["saline solution"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* 21-50 years old, non-traumatic low back pain for one week or less,\n\nExclusion Criteria:\n\n* fever, pregnancy, lactation, allergy or intolerance to study medication, suspected active oncologic, urologic, or gynecologic disease","healthyVolunteers":false,"sex":"ALL","minimumAge":"21 Years","maximumAge":"50 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Numerical Rating Scale (0-10), an Interval Pain Scale, on Which 0 Indicates no Pain and 10 Indicates the Worst Pain Imaginable","description":"Improvement in Numerical Rating Scale between the time of the emergency department visit and the one month telephone call is rated on an 11-point scale ranging from 0-10 with 0 indicating no pain and 10 indicating worse pain imaginable.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.1","spread":"3.0"},{"groupId":"OG001","value":"5.8","spread":"3.5"}]}]}]},{"type":"PRIMARY","title":"Functional Disability Scales","description":"The low back pain functional disability scale is the Roland Morris Disability questionnaire score (RMDQ). The RMDQ is a 24-item low back pain functional scale recommended for use in low back pain research.Higher scores signify greater low back-related functional impairment.0= no functional impairment, 24= severe functional impairment.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients Using Analgesics","description":"Use of analgesics for low back pain (within the previous 24 hours)","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"17","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":37},"commonTop":["Drowsiness","Stomach Pain","Other","Mood Change","Bloating (Gastrointestinal)"]}}}